Erman Akkus: Durable stable/partial response to atezo-beva in Hepatocellular Carcinoma

Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X:

“Durable stable/partial response to atezo-beva in Hepatocellular Carcinoma.

Significant proportion of HCC tumors become ghost tumors (radiologically persistent without viable tumor cells)

Durable: PR/SD >6 mo
IMbrave150
•CR, PR, SD: 8.9%, 22.1%, 44.2%
•77.8% of PRs and 28.5% SDs were durable
•Durable response -> better survival

Real-word, resection after atezo-beva
•pCR: 57.7% of PR tumors, 16.7% of SD tumors”

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab

Source: Erman Akkus/X

For more posts by Erman Akkus, visit oncodaily.com